Xiong Luo

Title: Innovations of Xiong Luo in Pharmaceutical Chemistry

Introduction

Xiong Luo is a notable inventor based in Shiga, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for therapeutic applications. His work focuses on enhancing the stability and efficacy of treatments for various medical conditions.

Latest Patents

Xiong Luo holds a patent for a compound known as 5'-dibenzyl phosphates of 5-azacytidine or 2'-deoxy-5-azacytidine. This invention relates to a novel compound represented by a specific formula, wherein R can be a hydroxy group or a hydrogen atom. The compound provides therapeutic agents that exhibit remarkable stability against cytidine deaminase, a metabolic enzyme. These agents can be absorbed in vivo through oral administration and effectively inhibit protein synthesis by being incorporated into nucleic acid biosynthesis. This innovation serves as a potential replacement for injection agents currently used in clinical settings for treating myeloma.

Career Highlights

Xiong Luo is associated with Ohara Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its potential to improve treatment options for patients suffering from myeloma and other related conditions.

Collaborations

Xiong Luo collaborates with Magoichi Sako, contributing to the innovative research environment at Ohara Pharmaceutical Co., Ltd. Their combined expertise enhances the development of new therapeutic agents.

Conclusion

Xiong Luo's contributions to pharmaceutical chemistry, particularly through his patented innovations, highlight his role as a key inventor in the field. His work promises to improve treatment methodologies and patient outcomes in the medical community.